Trial
NCT01944969
Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
H. Lundbeck A/S
Collaborators
Otsuka Pharmaceutical Co., Ltd.
Condition
Major Depressive Disorder
Intervention
Brexpiprazole
Why stopped
The study was terminated because the lead-in study (14571A) in elderly was terminated; see Detailed Description.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-17